Wallace Hall's most recent trade in Tvardi Therapeutics Inc. was a trade of 12,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Wallace Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | |
| Tvardi Therapeutics Inc | Wallace Hall | Director | Other type of transaction at price $ 0.00 per share. | 15 Apr 2025 | 202,044 | 202,044 | - | - | Common Stock | |
| Tvardi Therapeutics Inc | Wallace Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 202,044 | 202,044 | - | - | Common Stock | |
| Tvardi Therapeutics Inc | Wallace Hall | Director | Other type of transaction at price $ 0.00 per share. | 15 Apr 2025 | 44,712 | 44,712 | - | - | Common Stock | |
| Tvardi Therapeutics Inc | Wallace Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 44,712 | 44,712 | - | - | Common Stock |